NCT04345653View on ClinicalTrials.gov

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

June 5, 2020

Study Completion Date

May 10, 2021

Conditions
Covid19
Interventions
DRUG

Hydroxychloroquine Sulfate (HCQ)

Open-label, consecutive at-risk subjects allocation with chemoprophylaxis with HCQ.

Trial Locations (1)

08820

Hackensack Meridian Health - JFK Medical Center, Edison

All Listed Sponsors
lead

Hackensack Meridian Health

OTHER

NCT04345653 - Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers | Biotech Hunter | Biotech Hunter